AstraZeneca won cancer’s big meeting — again. Will that help it fulfill its $80 billion ambition?

Taking stock of the drug industry, from the lab to the medicine chest

June 3, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Marie Miller for STAT STAT+ | ASCO24: AstraZeneca won cancer's big meeting — again. Will that help it fulfill its $80 billion ambition? It's a harsh reality in the pharmaceutical business that winning streaks tend to end —– and cruelly. But AstraZeneca believes it has reason for optimism. By Matthew Herper STAT+ | Leading CRO to pay record fine for badly neglecting hundreds of beagles in breeding facility Inotiv pleaded guilty after some 400 dogs did not receive sufficient veterinary care or food, and were living in unsanitary conditions. By Ed Silverman STAT+ | Agios drug reduces blood transfusions in patients with beta-thalassemia, study shows The drug, mitapivat, reduced the need for blood transfusions in patients with a severe form of beta-thalassemia, an inherited blood disorder. By Adam Feuerstein Michael Conroy/AP STAT+ | Elevance PBM's president out as customers complain of prescription chaos The customer complaints coincide with major changes at CarelonRx, as Elevance juggles pharmacy delivery company switchovers. By Brittany Trang STAT+ | Structure Therapeutics oral GLP-1 drug led to weight loss in two studies The results appear to approach the levels of weight loss seen at 12 weeks in a separate Phase 2 study of Eli Lilly's GLP-1 pill called orforglipron. By Elaine Chen STAT+ | Delfi Diagnostics announces key data, study design for its liquid biopsy test Delfi is focusing on a single disease — lung cancer — where the utility of screening with existing technology is not in dispute. By Matthew Herper

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser